\-\ Texto\\:\\ \ \(0\)\
\-\ abdomen\\:\\ non\\-distended\\,\\ nabs\\ without\\ bruits\\.\\ \\ no\\ tenderness\\ to\\ palpation\\.\\ \\ no\\ guarding\\ or\\ rebound\\.\\ \ \(0\)\
\-\ back\\:\\ mild\\ right\\ cva\\ tenderness\\.\\ \ \(0\)\
\-\ creat\\ 2\\.4\ \(0\)\
\-\ multiple\\ axial\\ ct\\ views\\ of\\ the\\ abdomen\\ without\\ contrast\\ demonstrating\\ an\\ enlarged\\ right\\ kidney\\ with\\ loss\\ of\\ intrapelvic\\ \\ fat\\,\\ right\\-sided\\ dilation\\ of\\ collecting\\ system\\ with\\ proximal\\ right\\ ureteral\\ dilatation\\.\\ \\ no\\ evidence\\ of\\ radiopaque\\ stone\\ in\\ bilateral\\ ureters\\.\\ \\ small\\ stone\\ in\\ right\\ collecting\\ system\\.\ \(0\)\
\-\ right\\ hydronephrosis\ \(4\)\
\-\ left\\-sided\\ hydronephrosis\ \(2\)\
\-\ radiolucent\\ stone\\ secondary\\ to\\ protease\\ inhibitor\\ therapy\ \(1\)\
\-\ radiopaque\\ stone\\ undetected\\ on\\ ct\ \(0\)\
\-\ obstruction\\ secondary\\ to\\ neoplasm\ \(1\)\
\-\ 59\\ year\\-old\\ hiv\\ positive\\ male\\,\\ on\\ haart\\,\\ presenting\\ with\\ 4\\ day\\ history\\ of\\ right\\ flank\\ and\\ abdominal\\ pain\\.\\ \\ history\\ of\\ nephrolithiasis\\ since\\ beginning\\ protease\\ inhibitor\\ therapy\\.\ \(0\)\
\-\ protease\\ inhibitor\\ associated\\ nephrolithiasis\\ is\\ classically\\ seen\\ with\\ indinavir\\,\\ in\\ which\\ 10\\-25\\%\\ of\\ adult\\ patients\\ taking\\ the\\ drug\\ can\\ develop\\ stones\\.\\ \\ the\\ stones\\ are\\ classically\\ radiolucent\\ on\\ ct\\.\\ \\ given\\ the\\ poor\\ kidney\\ function\\ in\\ this\\ patient\\,\\ intravenous\\ contrast\\ was\\ unable\\ to\\ be\\ administered\\.\\ \\ however\\,\\ such\\ a\\ study\\ would\\ be\\ effective\\ in\\ evaluating\\ for\\ a\\ filling\\ defect\\ within\\ the\\ right\\ ureter\\ as\\ a\\ cause\\ of\\ the\\ hydronephrosis\\.\\ \\ other\\ options\\ for\\ further\\ radiological\\ evaluation\\ would\\ include\\ intravenous\\ pyelogram\\ and\\ retrograde\\ pyelography\\.\\ \\ however\\,\\ due\\ to\\ decreased\\ renal\\ function\\,\\ no\\ additional\\ studies\\ were\\ obtained\\,\\ and\\ the\\ case\\ was\\ managed\\ as\\ a\\ presumed\\ stone\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ protease\\:\\ 0\\.11206167488093007\ \(0\)\
\-\ stone\\:\\ 0\\.09006716594276826\ \(0\)\
\-\ inhibitor\\:\\ 0\\.07763730791776638\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.05472024047605486\ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.04263837957667997\ \(0\)\
\-\ classically\\:\\ 0\\.042261669724384776\ \(0\)\
\-\ intrapelvic\\:\\ 0\\.037353891626976686\ \(0\)\
\-\ \\-left\\-sided\\:\\ 0\\.037353891626976686\ \(0\)\
\-\ \\-radiolucent\\:\\ 0\\.037353891626976686\ \(0\)\
\-\ \\-radiopaque\\:\\ 0\\.037353891626976686\ \(0\)\
\-\ indinavir\\:\\ 0\\.037353891626976686\ \(0\)\
\-\ stones\\:\\ 0\\.037259981492965256\ \(0\)\
\-\ collecting\\:\\ 0\\.03695907735349992\ \(0\)\
\-\ intravenous\\:\\ 0\\.0359390461479925\ \(0\)\
\-\ \\-obstruction\\:\\ 0\\.03441682730257014\ \(0\)\
\-\ haart\\:\\ 0\\.03441682730257014\ \(0\)\
\-\ pyelogram\\:\\ 0\\.03147976297816359\ \(0\)\
\-\ pyelography\\:\\ 0\\.03147976297816359\ \(0\)\
\-\ function\\:\\ 0\\.030699674348104136\ \(0\)\
\-\ 10\\-25\\:\\ 0\\.030534239455645755\ \(0\)\
\-\ undetected\\:\\ 0\\.02910850963945417\ \(0\)\
\-\ system\\:\\ 0\\.028512542122040657\ \(0\)\
\-\ nabs\\:\\ 0\\.028043617994196093\ \(0\)\
\-\ creat\\:\\ 0\\.028043617994196093\ \(0\)\
\-\ right\\:\\ 0\\.026743313405817443\ \(0\)\
\-\ would\\:\\ 0\\.025770905749339743\ \(0\)\
\-\ kidney\\:\\ 0\\.025511724195339064\ \(0\)\
\-\ radiopaque\\:\\ 0\\.025348750338602892\ \(0\)\
\-\ bruits\\:\\ 0\\.024660110806832655\ \(0\)\
\-\ cva\\:\\ 0\\.024453372823063875\ \(0\)\
\-\ non\\-distended\\:\\ 0\\.022668570004943947\ \(0\)\
\-\ 2\\.4\\:\\ 0\\.022538181620762786\ \(0\)\
\-\ beginning\\:\\ 0\\.022538181620762786\ \(0\)\
\-\ ureters\\:\\ 0\\.02228885746812324\ \(0\)\
\-\ radiolucent\\:\\ 0\\.02228885746812324\ \(0\)\
\-\ tenderness\\:\\ 0\\.022024680702386723\ \(0\)\
\-\ retrograde\\:\\ 0\\.02172304648242611\ \(0\)\
\-\ abdomen\\:\\ 0\\.02145240900759065\ \(0\)\
\-\ ureteral\\:\\ 0\\.021223965822865162\ \(0\)\
\-\ radiological\\:\\ 0\\.0209504975129602\ \(0\)\
\-\ administered\\:\\ 0\\.02086312765193166\ \(0\)\
\-\ effective\\:\\ 0\\.020611333497394364\ \(0\)\
\-\ presumed\\:\\ 0\\.02053062080684058\ \(0\)\
\-\ secondary\\:\\ 0\\.020246016665328877\ \(0\)\
\-\ however\\:\\ 0\\.020164136064381954\ \(0\)\
\-\ evaluating\\:\\ 0\\.02014862463313593\ \(0\)\
\-\ hiv\\:\\ 0\\.020076190593477875\ \(0\)\
\-\ guarding\\:\\ 0\\.01960111729635624\ \(0\)\
\-\ ureter\\:\\ 0\\.019537397477014967\ \(0\)\
\-\ 59\\:\\ 0\\.019474621689789792\ \(0\)\
\-\ managed\\:\\ 0\\.019474621689789792\ \(0\)\
\-\ therapy\\:\\ 0\\.019361362680005195\ \(0\)\
\-\ taking\\:\\ 0\\.019232425020976454\ \(0\)\
\-\ rebound\\:\\ 0\\.018947936449630567\ \(0\)\
\-\ drug\\:\\ 0\\.01857924417425078\ \(0\)\
\-\ adult\\:\\ 0\\.01814796157124255\ \(0\)\
\-\ develop\\:\\ 0\\.018057803103245583\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.01767426917298782\ \(0\)\
\-\ options\\:\\ 0\\.01759355648243403\ \(0\)\
\-\ dilation\\:\\ 0\\.017067909666035816\ \(0\)\
\-\ without\\:\\ 0\\.01705095903693356\ \(0\)\
\-\ flank\\:\\ 0\\.017032745247329478\ \(0\)\
\-\ unable\\:\\ 0\\.016728745650469983\ \(0\)\
\-\ poor\\:\\ 0\\.016295360696569904\ \(0\)\
\-\ contrast\\:\\ 0\\.016209963447524622\ \(0\)\
\-\ demonstrating\\:\\ 0\\.015718529449431855\ \(0\)\
\-\ dilatation\\:\\ 0\\.01551791029435898\ \(0\)\
\-\ ct\\:\\ 0\\.015194537966848004\ \(0\)\
\-\ views\\:\\ 0\\.014924633895093246\ \(0\)\
\-\ presenting\\:\\ 0\\.014757625553818344\ \(0\)\
\-\ no\\:\\ 0\\.01458379916447122\ \(0\)\
\-\ filling\\:\\ 0\\.014577288204586156\ \(0\)\
\-\ additional\\:\\ 0\\.014518841924364395\ \(0\)\
\-\ defect\\:\\ 0\\.013554014094491215\ \(0\)\
\-\ studies\\:\\ 0\\.013523308973640508\ \(0\)\
\-\ year\\-old\\:\\ 0\\.013299850091941595\ \(0\)\
\-\ since\\:\\ 0\\.013299850091941595\ \(0\)\
\-\ obtained\\:\\ 0\\.01287231398620272\ \(0\)\
\-\ given\\:\\ 0\\.01241277284964552\ \(0\)\
\-\ enlarged\\:\\ 0\\.012354326569423755\ \(0\)\
\-\ neoplasm\\:\\ 0\\.012331171931830203\ \(0\)\
\-\ cause\\:\\ 0\\.012251112824372738\ \(0\)\
\-\ palpation\\:\\ 0\\.01208448762859344\ \(0\)\
\-\ back\\:\\ 0\\.011945196336218124\ \(0\)\
\-\ study\\:\\ 0\\.011913692190084573\ \(0\)\
\-\ positive\\:\\ 0\\.01174951521306829\ \(0\)\
\-\ further\\:\\ 0\\.011514593821187535\ \(0\)\
\-\ day\\:\\ 0\\.011495592497258176\ \(0\)\
\-\ \\,\\:\\ 0\\.01147076548802065\ \(0\)\
\-\ such\\:\\ 0\\.01131920673661378\ \(0\)\
\-\ be\\:\\ 0\\.011167429858846858\ \(0\)\
\-\ fat\\:\\ 0\\.011012340351193362\ \(0\)\
\-\ as\\:\\ 0\\.010954046660119727\ \(0\)\
\-\ renal\\:\\ 0\\.010879133684144362\ \(0\)\
\-\ proximal\\:\\ 0\\.010870945685199217\ \(0\)\
\-\ decreased\\:\\ 0\\.010765916960697286\ \(0\)\
\-\ evaluation\\:\\ 0\\.010517960999266135\ \(0\)\
\-\ loss\\:\\ 0\\.010510441408764575\ \(0\)\
\-\ axial\\:\\ 0\\.01033386218672827\ \(0\)\
\-\ include\\:\\ 0\\.01015743003402664\ \(0\)\
\-\ 4\\:\\ 0\\.010088864004995955\ \(0\)\
\-\ history\\:\\ 0\\.010001818116161723\ \(0\)\
\-\ due\\:\\ 0\\.009662191326071354\ \(0\)\
\-\ \\:\\:\\ 0\\.00957860013551411\ \(0\)\
\-\ mild\\:\\ 0\\.009534972262420071\ \(0\)\
\-\ evidence\\:\\ 0\\.009493400776978295\ \(0\)\
\-\ patients\\:\\ 0\\.009371078810872992\ \(0\)\
\-\ on\\:\\ 0\\.009202004394475782\ \(0\)\
\-\ abdominal\\:\\ 0\\.00905050524628015\ \(0\)\
\-\ to\\:\\ 0\\.009048053144978523\ \(0\)\
\-\ in\\:\\ 0\\.00892790741822574\ \(0\)\
\-\ bilateral\\:\\ 0\\.008787363259806965\ \(0\)\
\-\ associated\\:\\ 0\\.008544332889439414\ \(0\)\
\-\ \\%\\:\\ 0\\.008446275565025457\ \(0\)\
\-\ was\\:\\ 0\\.00837523323909904\ \(0\)\
\-\ other\\:\\ 0\\.008345926053823935\ \(0\)\
\-\ small\\:\\ 0\\.008341420696530164\ \(0\)\
\-\ were\\:\\ 0\\.008221552274109836\ \(0\)\
\-\ can\\:\\ 0\\.00821280657825877\ \(0\)\
\-\ case\\:\\ 0\\.007921628952827418\ \(0\)\
\-\ multiple\\:\\ 0\\.007626296624912156\ \(0\)\
\-\ seen\\:\\ 0\\.007155201758761399\ \(0\)\
\-\ within\\:\\ 0\\.00690733647621221\ \(0\)\
\-\ which\\:\\ 0\\.006759087234078596\ \(0\)\
\-\ a\\:\\ 0\\.006722030539298327\ \(0\)\
\-\ male\\:\\ 0\\.006547481092743531\ \(0\)\
\-\ for\\:\\ 0\\.00617888261561623\ \(0\)\
\-\ an\\:\\ 0\\.005007054509681059\ \(0\)\
\-\ are\\:\\ 0\\.00493590623953221\ \(0\)\
\-\ pain\\:\\ 0\\.004422068506486164\ \(0\)\
\-\ or\\:\\ 0\\.004243740461710625\ \(0\)\
\-\ the\\:\\ 0\\.004100614376802461\ \(0\)\
\-\ this\\:\\ 0\\.0040726153106531065\ \(0\)\
\-\ of\\:\\ 0\\.003949281382982658\ \(0\)\
\-\ patient\\:\\ 0\\.003629626825916898\ \(0\)\
\-\ is\\:\\ 0\\.0023825880440030748\ \(0\)\
\-\ and\\:\\ 0\\.002288250072867184\ \(0\)\
\-\ \\.\\:\\ 0\\.002256326446865229\ \(0\)\
\-\ with\\:\\ 0\\.001983121628642199\ \(0\)\
